Early Mortality in Patients Undergoing Adjuvant Chemotherapy for Non-Small Cell Lung Cancer

Early mortality with the use of adjuvant chemotherapy after complete resection of NSCLC is a clinical concern. The risk is higher in patients older than 70 years, with higher comorbidity scores and a prolonged length of stay postoperatively.